An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: The trastuzumab case.

Auteurs : Ades F, Senterre C, Zardavas D, de Azambuja E, Popescu R, Parent F, Piccart-Gebhart M
Jaar : 2014
Journal : Eur. J. Cancer
Volume : 50(18)
Pagina's : 3089-97